Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hitoshi Kashiwagi"'
Autor:
Kenji Momo, Yoh Takekuma, Yuki Sato, Mitsuru Sugawara, Hiromitsu Oki, Hitoshi Kashiwagi, Yasuyuki Nasuhara, Shungo Imai, Takayuki Miyai
Publikováno v:
Biological & pharmaceutical bulletin. 44(10):1499-1505
A major adverse effect of benzbromarone is hepatotoxicity. Therefore, periodic liver function tests are required at least for the first 6 months of benzbromarone administration. However, it is not clear whether the relevant blood tests are implemente
Publikováno v:
International Journal of Clinical Pharmacy. 42:1369-1373
Background The concurrent use of nonsteroidal anti-inflammatory drugs, renin-angiotensin-aldosterone system blockers, and diuretics, known as a "triple-whammy," is related to the occurrence of acute kidney injury. However, there are few reports regar
Publikováno v:
Pharmacoepidemiology and Drug Safety. 29:873-880
Purpose When prescribing nonsteroidal anti-inflammatory drugs (NSAIDs) for chronic kidney disease (CKD), patients' pathology and concomitant medications should be considered. In our pharmaceutical experience, NSAIDs are often prescribed by department
Publikováno v:
Biologicalpharmaceutical bulletin. 43(10)
The anti-inflammatory agent colchicine may cause toxic effects such as rhabdomyolysis, pancytopenia, and acute respiratory distress syndrome in cases of overdose and when patients have renal or liver impairment. As colchicine is a substrate for CYP3A
Autor:
Shotaro Maehana, Fumitaka Ushikubi, Takafumi Ichikawa, Yoshitaka Imamichi, Koh-ichi Yuhki, Fumiaki Kojima, Hidero Kitasato, Masaki Nakamura, Hiroki Sekiya, Hitoshi Kashiwagi
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO2-6
Autor:
Toshikatsu Okumura, Fumiaki Kojima, Yoshitaka Imamichi, Koh-ichi Yuhki, Shuh Narumiya, Hitoshi Kashiwagi, Fumitaka Ushikubi, Shima Kumei
Publikováno v:
The FASEB Journal. 32:2354-2365
Nonalcoholic steatohepatitis (NASH) is a hepatic manifestation of metabolic syndrome. Although the prostaglandin (PG)I2 receptor IP is expressed broadly in the liver, the role of PGI2-IP signaling in the development of NASH remains to be determined.
Autor:
Shima Kumei, Takahiro Horinouchi, Tsunehito Higashi, Fumiaki Kojima, Koh-ichi Yuhki, Soichi Miwa, Hitoshi Kashiwagi, Yoshitaka Imamichi, Fumitaka Ushikubi, Shuh Narumiya
Publikováno v:
TH Open, Vol 01, Iss 02, Pp e122-e129 (2017)
TH Open: Companion Journal to Thrombosis and Haemostasis
TH Open: Companion Journal to Thrombosis and Haemostasis
This is an open access article under the CC BY license.
The results of studies that were performed to determine whether cigarette smoking affects platelet function have been controversial, and the effects of nicotine- and tar-free cigarette smok
The results of studies that were performed to determine whether cigarette smoking affects platelet function have been controversial, and the effects of nicotine- and tar-free cigarette smok
Autor:
Yoshikazu Tasaki, Fumiaki Kojima, Koh-ichi Yuhki, Shuh Narumiya, Hitoshi Kashiwagi, Shima Kumei, Yoshitaka Imamichi, Fumitaka Ushikubi
Publikováno v:
Thrombosis and haemostasis. 119(8)
Platelets play an important role in both physiological hemostasis and pathological thrombosis. Thromboxane (TX) A2 and prostaglandin (PG) I2 are well known as a potent stimulator and an inhibitor of platelet function, respectively. Recently, PGE2 has
Autor:
Koh-ichi Yuhki, Koh Nakayama, Yoshitaka Imamichi, Tomohiro Hirata, Fumitaka Ushikubi, Hitoshi Kashiwagi, Shuh Narumiya
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 94:1-O
Autor:
Koh-ichi Yuhki, Yoshitaka Imamichi, Shuh Narumiya, Hitoshi Kashiwagi, Tomohiro Hirata, Fumitaka Ushikubi
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 93:2-O